Bio-IT World August 14, 2025
San Francisco biotech Openwater is pioneering a multi-purpose platform approach to medical device development, combining infrared light and low-intensity focused ultrasound technologies to create what CEO Aaron Timm describes as the “smartphone” of medical devices.
Nearly a decade in development, Openwater’s platform centers on two foundational devices: Open-Motion for blood monitoring and diagnosis, and Open-LIFU for therapeutic applications using low-energy sound waves. Neither device has FDA approval yet, but both are showing promising results across multiple therapeutic areas including oncology, stroke care, mental health, and long COVID treatment.
Platform Strategy Disrupts Traditional Development
The company’s open-source approach represents a significant departure from traditional medical device development. By licensing intellectual property...
Today's Sponsors
Today's Sponsor